Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Evaluation of Malva sylvestris formulation on radiation proctitis
IRCT2012101011064N1Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Jan 2013
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of mallow extract in radiation proctitis, sponsored by Tehran University of Medical Sciences. Started Jan 2013; status: completed.
02
Drugs
mallow extract
03
Conditions
radiation proctitis
Beyond the preview
Go deeper on IRCT2012101011064N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2012101011064N1.